Fifth Annual Chicago Supportive Oncology Conference

SUMMER 2009

Perspectives

Lab and Sample Quality Crucial in KRAS Testing

Letter from Singapore

Rethinking the Medicare Modernization Act

Health Reform, Fee Fix Are Looming

Cutting the Cost of Cancer Care: Payers Consider Novel Options

full text 110 kb

Brain Tumors

FDA Approves Bevacizumab After Unanimous ODAC Vote

New & Approved: Temodar for Injection

full text 71 kb

Breast Cancer

New Guidelines on Chemo, Counseling, Local Therapy

NCCN Guidelines Address Benefits and Drawbacks of MRI in Staging

Benefits Emerging for Intraoperative Radiation

Puberty Promoter KISS1 Shows Promise as a Suppressor of Tumor Metastasis

Primary Stage IV Resection May Aid Survival

Ablation Alternative to Radiotherapy Explored After Lumpectomy

full text 109 kb

Gastrointestinal Malignancies

NCCN Updates Guidelines on 'Unresectable' Colon Cancer

More Mutations Signal Anti-EGFR Antibody Resistance

Adjuvant Bevacizumab Fails to Improve Disease-Free Survival

90Y Microspheres Benefit Patients With Advanced HCC

Studies Back Microparticle Embolization for Unresectable HCC

NCCN Pancreatic Update Bolsters Systemic Recommendations

full text 96 kb

Genitourinary Malignancies

FDG-PET Can Often Change Bladder Cancer Management

Novel Urine Test May Help Detect Aggressive Prostate Cancers

Four Factors Can Help to Predict Individual Risk of Prostate Cancer

Lowering PSA Threshold Reveals Indolent Cancers

PSA-Doubling Time Key Predictor of Prostate Cancer Metastasis

Castration-Resistant Respond to MDV3100, Abiraterone Acetate

Early Data: Estrogen Patches Similar to LHRH Analogs

New & Approved: Degarelix

3-T, MR-Guided Biopsies Improve Tumor Detection

Provenge Vaccine Extends Survival in Prostate Cancer

Model Predicts Metastatic RCC Survival With Anti-VEGF Agents

Partial Nephrectomy of Large Tumors Saves Function

Adrenals May Be Left Intact During Most Partial Nephrectomies

Novel TKI AV-951 Is Active in Advanced Kidney Cancer

New & Approved: Afinitor

full text 187 kb

Gynecologic Malignancies

Tx Interval's Predictive Value Weak in Endometrial Cancer

Ovarian Ca Guidelines: New Chemo, Tips to Manage Reactions

Ovarian Stimulation for IVF May Increase Ovarian Cancer Risk

Data Support Upper Abdominal Surgery in Advanced Ovarian Cancer

full text 98 kb

Head and Neck Cancers

NCCN Updates Thyroid Carcinoma Recommendations

full text 125 kb

Hematologic Malignancies

NCCN Advises on Primary Cutaneous B-Cell Lymphomas

Gene Profiling May Identify Early-Stage High-Risk CTCL

Mycosis Fungoides Has Poor Prognosis in Young Black Women

New & Approved: Mozobil

Novel Elotuzumab and Panobinostat May Enhance Bortezomib

BiRD Therapy Maintains High Response Rates in MM

Thalidomide Combination Improves Response in Elderly Patients

Regimens Added to NCCN's Non-Hodgkin's Guidelines

Tandem ASCT as Effective as Autograft Plus Allograft in MM

full text 127 kb

Lung Cancer

NCCN Updates on NSCLC Reflect 'Important Advances'

Better Survival With Board-Certified General Thoracic Surgeons

Editorial: Lung Cancer 2009: Getting Serious About a Serious Disease

Study Challenges Routine Mediastinoscopy in Early NSCLC

Adding Breath-Hold Chest CT Improves Lung Cancer Evaluation

full text 99 kb

Melanoma/Sarcoma

Routine SLN Dissection Not Justified in Thin Melanomas

Scoring System Predicts Nodal Recurrence in Thin Melanomas

Isolated Limb Infusion for In-Transit Extremity Melanoma

full text 90 kb

Pediatric Cancers

JAK Mutations in Childhood Leukemia New Therapy Target

E.U. Approves Mifamurtide for Osteosarcoma; FDA Reviewing

full text 77 kb

Patient and Survivor Care

First NCCN Survivor Guidelines Smooth Transition to Primary Care

Secrecy, Uncertainty Denounced as Scary for Survivors

Hospice, Palliative Care-Not More Chemo-Say Some Payers

Top Palliative Care Articles of 2008

Acupuncture for Hot Flashes Demonstrates Long-Term Benefits

full text 136 kb

Practice Trends

CMS Expands PET Coverage in Solid Tumors, Myeloma

Mergers Can Add Clout While Keeping Small-Practice Identity

U.S. Courts Weigh Medicare Data Release Against Privacy

In-Office Pharmacies Benefit Patients, but Pose Dilemmas

full text 91 kb

Do you have a comment on a story in this issue?
Send Letters to the Editor to TOR@elsevier.com.

Copyright © 2009 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data.

Discussions, views, opinions, and recommendations as to medical procedures, products, choice of drugs, and drug dosages are the responsibility of the authors or advertisers. No responsibility is assumed by the Publisher, Editor, or Editorial Board for any injury and/or damage to persons or property as a matter of products liability, negligence, or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should be made.